eViralHepatitis Review eViralHepatitis Review eViralHepatitis Review
eViralHepatitis Review
HOME       NEWSLETTER ARCHIVE      CME/CE INFORMATION       PROGRAM DIRECTORS       EDIT PROFILE        RECOMMEND TO A COLLEAGUE
Spacer

Accreditation Statements

Physicians
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Nurses
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

The Institute for Johns Hopkins Nursing and the American Nurses Credentialing Center do not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.

Credit Designations

Physicians
eNewsletter: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Podcast: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
eNewsletter: This 1 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing. Each Newsletter carries a maximum of 1 contact hour, or a total of 6 contact hours for the six newsletters in this program. To obtain contact hours, you must complete this Education Activity and post-test before July 29, 2015.

Podcast: These paired 0.5 contact hour Educational Activities are provided by the Institute for Johns Hopkins Nursing. Each podcast carries a maximum of 0.5 contact hour, or a total of 3 contact hours for the 6 podcasts in this program. To obtain contact hours, you must complete this Education Activity and post-test before July 29, 2015.

Course Format
The eViralHepatitis Review Volume 3 series will consist of a monthly review of journal literature by key, pertinent topics, emailed as either a newsletter or podcast, to clinicians caring for patients with viral hepatitis. The timely commentary on current research, best practices and clinical management issues is provided by an expert panel of viral hepatitis specialists. The activities are delivered as 6 bi-monthly newsletters and 6 alternating podcasts. Participants will have up to 2 years to complete the 6 newsletters and 6 podcasts in order to earn CME credit.
Date of release: August 27, 2013
Expiration date: August 26, 2015
Internet CME Policy

The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. The Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals, and the public.

Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in an Internet-based CME program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services you request.

Statement of Responsibility

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Intended Audience

The target audience (clinicians) for this initiative includes: OB/GYNs, NPs, PAs, hepatologists, gastroenterologists, infectious disease physicians, community gastroenterologists and others who care for patients of Asian and West African descent in areas of high HBV prevalence.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:

    HCV
  • Identify and screen patients at risk for HCV
  • Describe new non-invasive techniques to stage liver disease
  • Interpret and apply best practices in identifying cirrhosis and HCC in patients infected with HCV
  • Recognize best practices in how to identify and manage HCV treatment-related side effects
  • Outline how newly emerging therapies apply to therapeutic decision-making in HCV infected and HIV/HCV co-infected patients

  • HBV
  • Identify and screen patients at risk for HBV
  • Describe new non-invasive techniques to stage liver disease
  • Interpret and apply best practices in identifying cirrhosis and HCC in patients infected with HBV
Launch Date

August 27, 2013; activities expire two years from the date of publication.

Faculty Disclosure

As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Faculty are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity:

Mark S. Sulkowski, MD, discloses that he has received grants for Abbott, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol Myers-Squibb, Gilead, Janssen, Merck, Roche, Vertex and has served as a consultant for Abbott, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol Myers-Squibb, Gilead, Janssen, Merck, Novartis, Pfizer, Roche, and Vertex.

Raymond T. Chung, MD, discloses that he has served as a consultant for Enanta and Idenix.

No other planners have indicated that they have any financial interest or relationships with a commercial entity.

Statement of Need

HCV

  • Clinicians do not adequately identify which of their patients are at highest risk for HCV infection or effectively interpret testing results.
  • Clinicians need to understand best practices in how to identify and manage HCV treatment-related side effects.
  • Clinicians need improved awareness of how newly emerging therapies impact therapeutic decision-making in HCV infected and HIV/HCV co-infected patients.
  • Clinicians are unaware of new non-invasive techniques to stage liver disease.
  • Clinicians need to understand best practices in identifying cirrhosis and HCC in patients infected with HCV.

HBV
  • Clinicians do not effectively identify their patients at risk for HBV
  • Clinicians are unaware of new non-invasive techniques to stage liver disease.
  • Clinicians need to understand best practices in identifying cirrhosis and HCC in patients infected with HBV.

Disclaimer Statement

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

Successful Completion

To successfully complete this activity, participants must read the content, then link to The Johns Hopkins University School of Medicine's or The Institute for Johns Hopkins Nursing's website to complete the posttest and evaluation. Once you receive a passing grade, you can access and print your certificate of credit.

NOTE: If you have already registered for other Hopkins CME programs on their prospective websites simply enter the requested information when prompted.

There are no fees or prerequisites for this activity.

This activity is supported by educational grants from AbbVie, Inc., Boehringer Ingelheim Pharmaceuticals, Inc. and Genentech, Inc.

Confidentiality Disclaimer for Conference Attendees

I certify that I am attending a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.

I understand that while I am attending in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the Privacy Regulations). Protected health information is information about a person's health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.

“The Office of Continuing Medical Education at The Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only.”

For CME Questions, please contact the CME Office at (410) 955-2959 or e-mail cmenet@jhmi.edu.

For CME Certificates, please call (410) 502-9634.

Johns Hopkins University School of Medicine
Office of Continuing Medical Education
Turner 20/720 Rutland Avenue
Baltimore, Maryland 21205-2195

Reviewed and Approved by
General Counsel, Johns Hopkins Medicine (4/1/03)
Updated 4/09

Hardware & Software Requirements

Pentium 800 processor or greater, Windows 98/NT/2000/XP or Mac OS 9/X, Microsoft Internet Explorer 5.5 or later, 56K Modem or better, Windows Media Player 9.0 or later, 128 MB of RAM Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe Acrobat Reader, storage, Internet connectivity, and minimum connection speed.

Copyright © JHUSOM and eViralHepatitis Review  |  Presented by JHUSOM, IJHN in collaboration with DKBmed.

Spacer

Spacer
Newsletter Header

CME/CNE Information


Current Newsletter

Recommend to a colleague

AASLD
Hepatitis B Foundation
Hepatitis C Association
SCALE HBV

JHU Logo
The Institute for Johns Hopkins Nursing

Share on Facebook

 

 

PRIVACYSpacerLEGAL DISCLAIMERSpacerCONTACT US